In a move to perhaps boost Medtronic's (Dublin) Cardiac Rhythm and Heart Failure Division, the company is reporting its plan to acquire CardioInsight Technologies (Cleveland), a privately-held firm that has developed a new approach to improve the mapping of electrical disorders of the heart, for $93 million. Read More
